You can buy or sell CTI BioPharma and other stocks, options, ETFs, and crypto commission-free!
CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. Read More The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.
52 Week High
52 Week Low
Expected Mar 11, After Hours